<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02430857</url>
  </required_header>
  <id_info>
    <org_study_id>17-5-2015</org_study_id>
    <nct_id>NCT02430857</nct_id>
  </id_info>
  <brief_title>Osteopathy and Latent Hypothyroidism</brief_title>
  <official_title>Osteopathy and Latent Hypothyroidism: Effectiveness of Osteopathic Treatment on TSH in Patients With Latent Hypothyroidism</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Emanuel Amier Diekmann</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Diekmann, Emanuel Amier</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the effectiveness of stimulating the neurological segments c8-th5 in
      patients with latent hypothyroidism.

      One half of the participants will receive an osteopathic manuel treatment in order to
      stimulate the relevant segments, the other half will receive no treatment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with latent hypothyroidism show an increased hormone status in TSH and a normal
      hormone status in fT4. A study has shown that osteopathic treatment had positive effects to
      some symptoms in patients with latent hypothyroidism. The study was using the pain inventory
      as the instrument to measure the effect. In this study we want to evaluate the effectiveness
      of the treatment on the hormone status (TSH, fT4) The intervention group will receive a
      neurological osteopathic stimulation over 5 weeks. A parallel control group will not receive
      any therapy.

      A follow up blood screening (TSH, fT4) will be done. The results of both groups will be
      compared.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>October 2015</start_date>
  <completion_date type="Anticipated">January 2016</completion_date>
  <primary_completion_date type="Anticipated">October 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in TSH Concentration</measure>
    <time_frame>5 weeks</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Latent Hypothyroidism</condition>
  <arm_group>
    <arm_group_label>OMT-Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The OMT-group will get an osteopathic treatment once a week for 1 hour for 5 weeks. The blood will be screened again after the treatment.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Controll Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>This group will receive no treatment. A blood screening is made again after 5 weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>OMT</intervention_name>
    <description>Manuel osteopathic treatment of the spine</description>
    <arm_group_label>OMT-Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  latent hypothyroidism

        Exclusion Criteria:

          -  Factors that Alter Thyroxine and Triiodothyronine Binding in Serum

          -  Increased thyroxin-binding globulin

          -  Decreased thyroxin-binding globulin

          -  Binding inhibitors

          -  Inherited Salicylates

          -  Pregnancy

          -  Androgens

          -  Furosemide

          -  Neonatal state

          -  Anabolic steroids

          -  Free fatty acids

          -  Estrogens

          -  Glucocorticoids

          -  Phenytoin

          -  Hepatitis

          -  Severe illness

          -  Carbamazepine

          -  Porphyria

          -  Hepatic failure

          -  nonsteroidal antiinflammatory drug (variable, transient)

          -  Heroin

          -  Nephrosis

          -  Heparin

          -  Methadone

          -  Nicotinic acid

          -  Mitotane L-Asparaginase

          -  5-Fluorouracil

          -  SERMS (e.g., tamoxifen, raloxifene)

          -  Perphenazine

          -  spinal pathologies
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Emanuel Diekmann, DO</last_name>
    <role>Principal Investigator</role>
    <affiliation>Praxis fuer Osteopathy</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Emanuel Diekmann, DO</last_name>
    <phone>0041788800341</phone>
    <email>Emanuel.diekmann@gmx.de</email>
  </overall_contact>
  <verification_date>May 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 27, 2015</study_first_submitted>
  <study_first_submitted_qc>April 27, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 30, 2015</study_first_posted>
  <last_update_submitted>May 17, 2015</last_update_submitted>
  <last_update_submitted_qc>May 17, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 19, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Diekmann, Emanuel Amier</investigator_affiliation>
    <investigator_full_name>Emanuel Amier Diekmann</investigator_full_name>
    <investigator_title>DO</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypothyroidism</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

